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Extractable and leachable compounds are a major obstacle in the implementation of single-use technologies. 
Recent studies show that a widely used trisarylphosphite-based processing stabilizer in plastic films, Irgafos 
168®, can breakdown from gamma irradiation. One of the breakdown compounds, bis(2,4-di-tert-
butylphenyl)phosphate (bDtBPP) has been found to leach out of single-use containers and suppress CHO cell 
growth. Due to its cytotoxic effect on bioprocessing cell lines, a targeted test for bDtBPP would be highly 
beneficial for pre-screening single-use bioprocessing containers and bags. 
 
In this study, an ultra-performance liquid chromatography method was developed for the separation and 
detection of bDtBPP and other extractable compounds related to Irgafos 168® (such as 2,4-di-tert-butylphenol, 
1,3-di-tert-butylbenzene, 2,4-di-tert-butylphenylphosphate and oxidised Irgafos 168®). The method was applied 
to an extractables study of three single-use plastic films, where bDtBPP and the oxidised form of Irgafos 168® 
were detected and quantified in all three films. Extraction methods using either a whole bag or a small piece of 
film were evaluated, and the latter shown to be more suitable for finding concentration per area of film and/or 
estimating the total load of extractables in the entire bag. The feasibility of monitoring bDtBPP during the 
bioprocess was investigated with a Waters PATROL UPLC System with a Flownamics® sampling probe as the 
sampling interface. bDtBPP spiked in cell culture medium was only detected in unfiltered or at-line injections, 
indicating that with the current sampling interface, monitoring of extractables and leachables is limited to at-line 
sampling. 
 
